Enter microdosing a strategy where people take smaller-than-standard doses of GLP-1s in hopes of reaping the benefits with fewer side effects
And this appear to be just the beginning
6 Challenges for clinical use of IGF-1R-silencing agents 6.1 Toxicity of IGF-1R antagonists Clinical trials of a large number IGF-1/2, IGF-1R, IRS-1, PI3K and mTOR antagonists have been abandoned due to limited anti-cancer activity, or to the toxicity of these agents (41, 53), further supporting the need to continue studies on LL6 and other molecules that are well tolerated in mice and effective at doses that are not toxic to normal cells (54)
Ongoing Research: Stay informed about new studies and findings
Safety, Who Benefits, and When Provider Evaluation Matters Glutathione supplementation is generally well-tolerated in oral and IV forms at standard doses (2501500 mg/day), with rare reported side effects
As Gales found, some people also experience a very real reduction in depression symptoms